Evidence map›Paper›PMID 37259292›Full record

ArticlePharmaceuticals (Basel, Switzerland)2023

Suvi T Häkkinen, Katarina Cankar, Liisa Nohynek, Jeroen van Arkel, Markus Laurel, Kirsi-Marja Oksman-Caldentey, Bart Van Droogenbroeck

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Suvi T HäkkinenVTT Technical Research Centre of Finland Ltd., Tietotie 2, 02044 Espoo, Finland.ORCID 0000-0001-6959-3148
Katarina CankarWageningen Plant Research, Wageningen University & Research, 6708 PB Wageningen, The Netherlands.
Liisa NohynekVTT Technical Research Centre of Finland Ltd., Tietotie 2, 02044 Espoo, Finland.
Jeroen van ArkelWageningen Plant Research, Wageningen University & Research, 6708 PB Wageningen, The Netherlands.ORCID 0000-0002-8217-8448
Markus LaurelVTT Technical Research Centre of Finland Ltd., Tietotie 2, 02044 Espoo, Finland.
Kirsi-Marja Oksman-CaldenteyVTT Technical Research Centre of Finland Ltd., Tietotie 2, 02044 Espoo, Finland.ORCID 0000-0003-2830-165X
Bart Van DroogenbroeckILVO Institute for Agriculture, Fisheries and Food Research, 9090 Melle, Belgium.

Funding

ERA-NET FACCE SurPlus EU-H2020 652615EU-H2020 project 'InnCoCells' 101000373
6 · The paper itself

Abstract

Industrial chicory is an important crop for its high dietary fibre content. Besides inulin, chicory taproots contain interesting secondary metabolite compounds, which possess bioactive properties. Hairy roots are differentiated plant cell cultures that have shown to be feasible biotechnological hosts for the production of several plant-derived molecules. In this study, hairy roots of industrial chicory cultivars were established, and their potential as a source of antimicrobial ingredients was assessed. It was shown that hot water extracts of hairy roots possessed antimicrobial activity against relevant human microbes, whereas corresponding chicory taproots did not show activity. Remarkably, a significant antimicrobial activity of hot water extracts of chicory hairy roots towards methicillin-resistant

Indexed as

antimicrobial activitychicoryhairy rootsMRSApolyphenolssesquiterpenes

Identifiers

PMID37259292
PMCPMC9967317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.